A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2

BACKGROUND: SARS‐CoV‐2 caused one of the most devastating pandemics in the recent history of mankind. Due to various countermeasures, including lock‐downs, wearing masks, and increased hygiene, the virus has been controlled in some parts of the world. More recently, the availability of vaccines, bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohsen, Mona O., Balke, Ina, Zinkhan, Simon, Zeltina, Villija, Liu, Xuelan, Chang, Xinyue, Krenger, Pascal S., Plattner, Kevin, Gharailoo, Zahra, Vogt, Anne‐Cathrine S., Augusto, Gilles, Zwicker, Marianne, Roongta, Salony, Rothen, Dominik A., Josi, Romano, da Costa, Joana J., Sobczak, Jan M., Nonic, Aleksandra, Brand, Lee‐Anne, Nuss, Katja, Martina, Byron, Speiser, Daniel E., Kündig, Thomas, Jennings, Gary T., Walton, Senta M., Vogel, Monique, Zeltins, Andris, Bachmann, Martin F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653185/
https://www.ncbi.nlm.nih.gov/pubmed/34496033
http://dx.doi.org/10.1111/all.15080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653185/
https://www.ncbi.nlm.nih.gov/pubmed/34496033
http://dx.doi.org/10.1111/all.15080

Ejemplares similares